Deciphering Proteasome Complexity: Harnessing the Potential of AffiREC Proteins for Research and Biotechnology

Proteasome Recombinant Proteins

 Refers to a collection of proteins produced using recombinant DNA technology that are specifically designed to mimic or represent components of the proteasome complex. These proteins are engineered for various research and biotechnological applications, including studying proteasome structure, function, regulation, and interactions. AffiREC proteins offer high purity, consistency, and versatility, making them valuable tools for investigating proteasome-related processes in vitro and in vivo.


Proteasome Recombinant Proteins Features 

High Purity

AffiREC proteins are produced using recombinant DNA technology, allowing for the generation of highly pure proteins devoid of contaminating cellular components.


These proteins are manufactured under controlled conditions, ensuring batch-to-batch consistency in terms of purity, concentration, and activity.


AffiREC proteins accurately mimic the structure and function of native proteasome components, providing researchers with reliable tools for studying proteasome biology

 Proteasome Recombinant Proteins Features 

Structural Biology

AffiREC proteins are utilized in structural studies to elucidate the three-dimensional architecture of the proteasome complex and its subunits using techniques such as X-ray crystallography, cryo-electron microscopy (cryo-EM), and nuclear magnetic resonance (NMR) spectroscopy.


Functional Assays

AffiREC proteins serve as essential components in biochemical assays designed to investigate proteasome activity, substrate specificity, and enzymatic kinetics. These assays enable researchers to evaluate the effects of small molecules, inhibitors, or activators on proteasome function.

Drug Discovery

AffiREC proteins are employed in drug screening assays to identify and characterize potential proteasome inhibitors or activators for therapeutic intervention. These proteins serve as targets for screening libraries of small molecules or natural compounds to discover novel drug candidates for diseases such as cancer and neurodegenerative disorders.

Biomedical Research

AffiREC proteins are used in biomedical research to study proteasome-related processes implicated in various diseases, including cancer, neurodegenerative diseases, autoimmune disorders, and inflammatory conditions. Researchers investigate proteasome function, regulation, and dysfunction in disease pathogenesis and progression.

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provided both a filter and a template to use.
Dengue Outbreak in Brazil Utilizing Recombinant Proteins for Vaccine Development and Surveillance